Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Net Cash Flow (2023 - 2025)

Historic Net Cash Flow for SeaStar Medical Holding (ICUCW) over the last 3 years, with Q3 2025 value amounting to $7.5 million.

  • SeaStar Medical Holding's Net Cash Flow rose 72624.58% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year increase of 48143.35%. This contributed to the annual value of $1.6 million for FY2024, which is 117364.34% up from last year.
  • According to the latest figures from Q3 2025, SeaStar Medical Holding's Net Cash Flow is $7.5 million, which was up 72624.58% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, SeaStar Medical Holding's Net Cash Flow ranged from a high of $7.5 million in Q3 2025 and a low of -$3.8 million during Q2 2024
  • For the 3-year period, SeaStar Medical Holding's Net Cash Flow averaged around $1.2 million, with its median value being $678000.0 (2023).
  • Over the last 5 years, SeaStar Medical Holding's Net Cash Flow had its largest YoY gain of 140500.0% in 2024, and its largest YoY loss of 43932.58% in 2024.
  • SeaStar Medical Holding's Net Cash Flow (Quarter) stood at $103000.0 in 2023, then crashed by 355.34% to -$263000.0 in 2024, then surged by 2936.88% to $7.5 million in 2025.
  • Its Net Cash Flow was $7.5 million in Q3 2025, compared to $1.0 million in Q2 2025 and $3.5 million in Q1 2025.